Cited by 1,016

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Triglyceride Metabolism in the Liver

Open access

Alves‐Bezerra, Michele, Cohen, David E.·2017·Comprehensive Physiology

Open this paper in CoChat — free account

Abstract

Triglyceride molecules represent the major form of storage and transport of fatty acids within cells and in the plasma. The liver is the central organ for fatty acid metabolism. Fatty acids accrue in liver by hepatocellular uptake from the plasma and by de novo biosynthesis. Fatty acids are eliminated by oxidation within the cell or by secretion into the plasma within triglyceride-rich very low-density lipoproteins. Notwithstanding high fluxes through these pathways, under normal circumstances the liver stores only small amounts of fatty acids as triglycerides. In the setting of overnutrition and obesity, hepatic fatty acid metabolism is altered, commonly leading to the accumulation of triglycerides within hepatocytes, and to a clinical condition known as nonalcoholic fatty liver disease (NAFLD). In this review, we describe the current understanding of fatty acid and triglyceride metabolism in the liver and its regulation in health and disease, identifying potential directions for future research. Advances in understanding the molecular mechanisms underlying the hepatic fat accumulation are critical to the development of targeted therapies for NAFLD. © 2018 American Physiological Society. Compr Physiol 8:1-22, 2018.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/cphy.c170012

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
Cargo recognition and trafficking in selective autophagy
Stolz, A., Ernst, A., & Dikic, I. (2014) · Nature Cell Biology · doi:10.1038/ncb2979 · Cited by 1,207
Thematic review series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis
Yen, C.-L. E., Stone, S. J., Koliwad, S., Harris, C., & Farese, R. V. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800018-jlr200 · Cited by 1,105

Show all 35 references

Research works printed but not linked: 262

10.1074/jbc.274.50.35577 · DOI
10.1016/j.biochi.2005.04.015 · DOI
10.1016/j.cgh.2015.07.029 · DOI · Paper page
10.1146/annurev.biochem.67.1.199 · DOI
10.1074/jbc.273.10.5678 · DOI · Paper page
10.1016/j.jnutbio.2010.01.005 · DOI
10.1194/jlr.M700102-JLR200 · DOI
10.1016/j.cca.2005.12.026 · DOI · Paper page
10.1038/nrendo.2016.124 · DOI
10.1210/jc.2005-1709 · DOI · Paper page
10.1194/jlr.M600413-JLR200 · DOI · Paper page
10.1016/0009-3084(85)90060-X · DOI
Baum CL, 1993, Regulation of sterol carrier protein‐2 gene expression in rat liver and small intestine, J Lipid Res, 34, 729, 10.1016/S0022-2275(20)39694-2 · DOI
10.1002/hep.26226 · DOI · Paper page
10.2337/db07-1383 · DOI
10.1002/hep.26222 · DOI
10.1073/pnas.87.9.3484 · DOI
10.1016/0026-0495(95)90013-6 · DOI
10.1002/hep.26672 · DOI · Paper page
10.1016/j.ceb.2006.06.008 · DOI
10.1194/jlr.M600299‐JLR200 · DOI · Paper page
10.1016/0167-0115(90)90089-F · DOI
10.1152/ajpgi.00413.2005 · DOI · Paper page
10.1016/j.jmb.2011.07.034 · DOI
10.1042/bj2310439 · DOI
10.1074/jbc.M409340200 · DOI
10.1016/0163-7827(84)90001-8 · DOI · Paper page
10.1002/hep.20466 · DOI · Paper page
10.1194/jlr.M009407 · DOI
10.1074/jbc.M109.036665 · DOI
10.1194/jlr.M001966 · DOI
10.1016/0005-2760(87)90261-X · DOI
10.2174/187153012800493459 · DOI
10.1073/pnas.0609140103 · DOI
10.1152/ajpregu.00177.2011 · DOI
10.1016/j.yexcr.2015.10.021 · DOI
10.1073/pnas.95.22.13018 · DOI · Paper page
10.1194/jlr.M016931 · DOI
10.1016/j.cell.2009.05.036 · DOI · Paper page
10.1016/j.cmet.2005.04.002 · DOI
10.1128/MCB.26.3.1063-1076.2006 · DOI · Paper page
10.1172/JCI0214672 · DOI · Paper page
10.1016/0026-0495(92)90221-U · DOI · Paper page
10.1074/jbc.M708151200 · DOI
10.1161/ATVBAHA.108.171538 · DOI
10.1073/pnas.0931394100 · DOI
10.4161/adip.21853 · DOI
10.1055/s‐0033‐1358519 · DOI
10.1016/S0163-7827(03)00051-1 · DOI · Paper page
10.1146/annurev.nutr.20.1.77 · DOI · Paper page
10.1074/jbc.R115.663260 · DOI
10.1097/MOL.0b013e32836139df · DOI
10.4161/auto.25063 · DOI · Paper page
10.2337/diabetes.54.10.3032 · DOI
10.1016/S0021-9258(17)47265-6 · DOI
10.1016/j.febslet.2007.07.084 · DOI
10.1016/j.biochi.2004.11.008 · DOI · Paper page
10.1093/abbs/gms008 · DOI
10.1152/ajpendo.2002.282.1.E46 · DOI
10.1016/S1262-3636(07)70061-7 · DOI · Paper page
10.1074/jbc.M409598200 · DOI
10.1053/j.gastro.2006.02.006 · DOI · Paper page
10.1074/jbc.M610745200 · DOI · Paper page
10.1146/annurev.biochem.66.1.199 · DOI · Paper page
10.1007/978-1-4615-4793-8_51 · DOI
10.1074/jbc.272.32.20299 · DOI
10.1016/j.biochi.2004.09.018 · DOI · Paper page
10.1007/s11010-005-9034-1 · DOI
10.3390/ijms15022991 · DOI
10.1371/journal.pone.0116587 · DOI
10.1126/scisignal.2004111 · DOI
10.1002/hep.23280 · DOI · Paper page
10.1042/bj3230001 · DOI · Paper page
10.1021/bi960545z · DOI
10.1152/ajpendo.00226.2010 · DOI
10.1126/science.1130773 · DOI · Paper page
10.1111/j.1463-1326.2010.01275.x · DOI · Paper page
10.1016/j.tem.2013.01.003 · DOI
10.1016/j.cmet.2006.08.005 · DOI · Paper page
10.1038/nature09968 · DOI · Paper page
10.1042/bj3360033 · DOI
10.5551/jat.2055 · DOI
10.1016/j.bbamcr.2003.10.018 · DOI · Paper page
10.1016/S0022-2275(20)37747-6 · DOI
10.1007/s11626-005-0002-6 · DOI
10.1074/jbc.M509612200 · DOI
10.1194/jlr.M300403-JLR200 · DOI
10.1055/s-0033-1358521 · DOI
10.1097/MOL.0b013e328328d0bb · DOI
10.1016/S0962-8924(00)89054-6 · DOI
Gordon GB., 1977, Saturated free fatty acid toxicity. II. Lipid accumulation, ultrastructural alterations, and toxicity in mammalian cells in culture, Exp Mol Pathol, 27, 262‐276
10.1007/BF02522684 · DOI
10.1172/JCI46069 · DOI · Paper page
10.1146/annurev-nutr-071813-105541 · DOI · Paper page
10.1074/jbc.M807882200 · DOI
10.1073/pnas.1110817108 · DOI
10.1194/jlr.M035519 · DOI
10.1074/jbc.M503181200 · DOI
10.1074/jbc.M910350199 · DOI · Paper page
10.1016/S0005-2760(97)00096-9 · DOI
10.1111/j.1872‐034X.2008.00382.x · DOI · Paper page
10.1194/jlr.M900058-JLR200 · DOI
10.1021/bi0477891 · DOI
10.1074/jbc.M202923200 · DOI
10.1172/JCI118645 · DOI
Hyslop PA, 1982, Changes in the composition and fluidity of membranes in obese (ob/ob) mice: a study of hepatic microsomal NADPH‐cytochrome P450 oxidoreductase activity, Int J Obes, 6, 279
10.1152/ajpendo.90899.2008 · DOI · Paper page
10.1074/jbc.M407841200 · DOI · Paper page
10.1016/j.bbalip.2011.09.017 · DOI · Paper page
10.1002/hep.26126 · DOI
10.1016/j.cmet.2012.03.005 · DOI · Paper page
10.1096/fj.11-202853 · DOI
10.1042/CS20080306 · DOI
10.1080/00365520802008140 · DOI
10.1016/j.tcb.2012.05.006 · DOI · Paper page
10.1038/ncb3166 · DOI · Paper page
10.1007/s00535-013-0758-5 · DOI · Paper page
10.2174/1389450116666150408103318 · DOI
10.1186/1476-5926-6-4 · DOI
10.1146/annurev.nutr.17.1.77 · DOI · Paper page
10.1097/MOL.0000000000000057 · DOI
10.1146/annurev-nutr-071813-105410 · DOI · Paper page
10.1016/j.plipres.2010.04.001 · DOI
10.1042/BJ20041896 · DOI
10.1007/BF00231387 · DOI
10.1096/fj.09‐144519 · DOI · Paper page
Kohjima M, 2007, Re‐evaluation of fatty acid metabolism‐related gene expression in nonalcoholic fatty liver disease, Int J Mol Med, 20, 351
10.7150/ijms.8.599 · DOI
10.1002/dmrr.997 · DOI
10.1006/bbrc.1997.7214 · DOI
10.1016/j.plipres.2009.05.001 · DOI · Paper page
10.1016/j.cmet.2006.03.005 · DOI · Paper page
10.1007/s00018-006-6600-y · DOI
10.1053/j.gastro.2010.03.033 · DOI · Paper page
10.1128/MCB.15.6.3012 · DOI
10.1006/abbi.2001.2604 · DOI
10.1152/ajpendo.00300.2004 · DOI
10.1210/edrv.23.2.0461 · DOI · Paper page
10.2337/db07-0040 · DOI
10.1074/jbc.M109.022467 · DOI
10.1016/j.cmet.2008.06.013 · DOI
10.1016/S0022-2275(20)37412-5 · DOI
10.1074/jbc.M408507200 · DOI
10.1194/jlr.M400010-JLR200 · DOI
10.1194/jlr.R200012-JLR200 · DOI · Paper page
10.1053/j.gastro.2015.09.042 · DOI · Paper page
10.1053/j.gastro.2012.03.003 · DOI
10.1194/jlr.M800013-JLR200 · DOI
10.1073/pnas.0603115103 · DOI · Paper page
10.1021/bi0346749 · DOI
10.1016/0014-5793(84)80752-8 · DOI
10.1172/JCI200317223 · DOI · Paper page
10.1016/j.cmet.2008.03.003 · DOI · Paper page
10.1016/S0022-2275(20)33379-4 · DOI · Paper page
10.1074/jbc.M111.256008 · DOI
10.1016/S0006-291X(02)02466-X · DOI
10.2337/diabetes.48.1.121 · DOI
10.1136/gut.2010.222844 · DOI · Paper page
10.1194/jlr.M046961 · DOI
10.1016/j.cmet.2007.05.005 · DOI · Paper page
10.1136/gutjnl‐2015‐310798 · DOI · Paper page
10.1016/j.bbrc.2005.12.121 · DOI
Muoio DM, 1999, AMP‐activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: Evidence that sn‐glycerol‐3‐phosphate acyltransferase is a novel target, Biochem J, 338, 783, 10.1042/bj3380783 · DOI · Paper page
10.1016/j.plipres.2008.08.001 · DOI · Paper page
Nagle CA, 2007, Hepatic overexpression of glycerol‐sn‐3‐phosphate acyltransferase‐1 causes insulin resistance, FASEB J, 21, A699, 10.1096/fasebj.21.5.A699-b · DOI
10.1194/jlr.M700592-JLR200 · DOI
10.1152/ajpgi.00436.2015 · DOI
10.1074/jbc.M309377200 · DOI · Paper page
10.1002/hep.21369 · DOI
10.1242/jcs.025452 · DOI
10.1093/dnares/dsi003 · DOI
10.1016/j.molmet.2016.02.002 · DOI
10.1007/s13105-011-0110-6 · DOI
10.1002/hep.24006 · DOI · Paper page
10.1172/JCI32752 · DOI · Paper page
10.1042/bj3230017 · DOI
10.1007/s12013‐013‐9623‐7 · DOI
10.1194/jlr.M100404-JLR200 · DOI
10.1083/jcb.152.5.1057 · DOI · Paper page
10.1146/annurev.nutr.27.061406.093618 · DOI · Paper page
10.1055/s-2001-12928 · DOI
10.1042/bj2990165 · DOI
10.1074/jbc.M800533200 · DOI · Paper page
10.1073/pnas.1113036109 · DOI · Paper page
10.1038/ng.257 · DOI · Paper page
10.1042/bj2900321 · DOI
10.1194/jlr.M046607 · DOI
10.1053/gast.2001.23256 · DOI · Paper page
Sanyal AJ, 2015, A lipidomic readout of disease progression in a diet‐induced mouse model of nonalcoholic fatty liver disease, Trans Am Clin Climatol Assoc, 126, 271
10.1152/ajpendo.00513.2004 · DOI · Paper page
10.1016/j.cmet.2014.06.009 · DOI · Paper page
10.1074/jbc.270.33.19269 · DOI · Paper page
10.1002/hep.27667 · DOI · Paper page
10.1007/s11745-007-3111-z · DOI
10.1172/JCI118342 · DOI
10.1101/gad.12.8.1189 · DOI · Paper page
10.1016/j.bbalip.2015.01.004 · DOI
10.1016/S0163-7827(97)00003-9 · DOI · Paper page
10.1007/s11033-010-0140-0 · DOI
10.1016/j.jchemneu.2004.02.006 · DOI · Paper page

200 of 262 shown

Small metabolites, possible big changes: A microbiota-centered view of non-alcoholic fatty liver disease
Chu, H., Duan, Y., Yang, L., & Schnabl, B. (2019) · Gut · doi:10.1136/gutjnl-2018-316307 · Cited by 354
Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data
Zhang, M. J., Hou, K., Dey, K. K., Sakaue, S., Jagadeesh, K. A., Weinand, K., Taychameekiatchai, A., Rao, P., Pisco, A. O., Zou, J., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01167-z · Cited by 302
The Regulation of Fat Metabolism during Aerobic Exercise
Muscella, A., Stefàno, E., Lunetti, P., Capobianco, L., & Marsigliante, S. (2020) · Biomolecules · doi:10.3390/biom10121699 · Cited by 237
Hepatic transcriptional responses to fasting and feeding
Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes & Development · doi:10.1101/gad.348340.121 · Cited by 126
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
Tang, Y., Huang, J., Zhang, W. Y., Qin, S., Yang, Y. X., Ren, H., Yang, Q.-B., & Hu, H. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819878046 · Cited by 85
The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)
Thondam, S. K., Cuthbertson, D. J., & Wilding, J. P. H. (2020) · Peptides · doi:10.1016/j.peptides.2019.170208 · Cited by 77
Triglyceride-rich lipoproteins and cardiovascular diseases
Xu, D., Xie, L., Cheng, C., Xue, F., & Sun, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1409653 · Cited by 73
Large neutral amino acid levels tune perinatal neuronal excitability and survival
Knaus, L. S., Basilico, B., Malzl, D., Gerykova Bujalkova, M., Smogavec, M., Schwarz, L. A., Gorkiewicz, S., Amberg, N., Pauler, F. M., Knittl-Frank, C., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.037 · Cited by 70
The Role of Lipids, Lipid Metabolism and Ectopic Lipid Accumulation in Axon Growth, Regeneration and Repair after CNS Injury and Disease
Roy, D., & Tedeschi, A. (2021) · Cells · doi:10.3390/cells10051078 · Cited by 68
Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin
Raffaele, M., Kovacovicova, K., Frohlich, J., Lo Re, O., Giallongo, S., Oben, J. A., Faldyna, M., Leva, L., Giannone, A. G., Cabibi, D., et al. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00731-0 · Cited by 60
One size does not fit all; practical, personal tailoring of the diet to NAFLD patients
Zelber‐Sagi, S., Grinshpan, L. S., Ivancovsky‐Wajcman, D., Goldenshluger, A., & Gepner, Y. (2022) · Liver International · doi:10.1111/liv.15335 · Cited by 49
A human liver chimeric mouse model for non-alcoholic fatty liver disease
Bissig-Choisat, B., Alves-Bezerra, M., Zorman, B., Ochsner, S. A., Barzi, M., Legras, X., Yang, D., Borowiak, M., Dean, A. M., York, R. B., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100281 · Cited by 49
Self-citation
In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions
Zhu, Z., Zhang, X., Pan, Q., Zhang, L., & Chai, J. (2023) · Liver Research · doi:10.1016/j.livres.2023.11.003 · Cited by 38
Diet-microbiome interactions in cancer
Abdeen, S. K., Mastandrea, I., Stinchcombe, N., Puschhof, J., & Elinav, E. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.013 · Cited by 36
New approaches to triglyceride reduction: is there any hope left?
Filtz, A., Parihar, S., Greenberg, G. S., Park, C. M., Scotti, A., Lorenzatti, D., Badimon, J. J., Soffer, D. E., Toth, P. P., Lavie, C. J., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100648 · Cited by 26
Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms
Heinle, J. W., DiJoseph, K., Sabag, A., Oh, S., Kimball, S. R., Keating, S., & Stine, J. G. (2023) · Nutrients · doi:10.3390/nu15112452 · Cited by 26
Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor
Wang, Z., Miu, K.-K., Zhang, X., Wan, A. T.-Y., Lu, G., Cheung, H.-H., Lee, H.-M., Kong, A. P.-S., Chan, J. C.-N., & Chan, W.-Y. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100179 · Cited by 22
Loss of Hepatic Leucine-Rich Repeat-Containing G-Protein Coupled Receptors 4 and 5 Promotes Nonalcoholic Fatty Liver Disease
Saponara, E., Penno, C., Orsini, V., Wang, Z.-Y., Fischer, A., Aebi, A., Matadamas-Guzman, M. L., Brun, V., Fischer, B., Brousseau, M., et al. (2023) · The American Journal of Pathology · doi:10.1016/j.ajpath.2022.10.008 · Cited by 22
Obesity and Exercise: New Insights and Perspectives
James, N. M., & Stanford, K. I. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf017 · Cited by 20
Hypertriglyceridemia: molecular and genetic landscapes
Scicchitano, P., Amati, F., Ciccone, M. M., D’Ascenzi, F., Imbalzano, E., Liga, R., Paolillo, S., Pastore, M. C., Rinaldi, A., Mattioli, A. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126364 · Cited by 13
An Autocrine Role for CXCL1 in Progression of Hepatocellular Carcinoma
DAHLQUIST, K. J. V., VOTH, L. C., FEE, A. J., & STOECKMAN, A. K. (2020) · Anticancer Research · doi:10.21873/anticanres.14628 · Cited by 13
The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease
Kotlyarova, A., Iskrina, A., & Kotlyarov, S. (2026) · International journal of molecular sciences · doi:10.3390/ijms27083399 · Cited by 10
Biochemical Changes Induced by the Administration of Cannabis sativa Seeds in Diabetic Wistar Rats
Munteanu, C., Mihai, M., Dulf, F., Ona, A., Muntean, L., Ranga, F., Urdă, C., Pop, D., Mihaiescu, T., Mârza, S. M., et al. (2023) · Nutrients · doi:10.3390/nu15132944 · Cited by 7

Authors: Alves‐Bezerra, M., & Cohen, D. E.
Venue: Comprehensive Physiology
Publisher: Wiley
Published: 2017-12-12
Volume: 8
Issue: 1
Pages: 1-22
ISSN: 2040-4603 (ISSN-L)
DOI: 10.1002/cphy.c170012
OpenAlex: W2788261792
Cited by: 1,016
References: 35
Type: other
Language: en
Open access: green
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Triglyceride Metabolism in the Liver

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources